(-0.54%) 4 569.78 points
(-0.11%) 36 204 points
(-0.84%) 14 185 points
(-1.99%) $2 048.20
Issued: 4 Dec 2023 @ 13:14
Previous signal: Dec 1 - 15:31
Return: 5.20 %
Live Chart Being Loaded With Signals
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China...
|EPS||$-0.460 ( 2023-10-26 )|
|Last Dividend||$0 ( N/A )|
|Next Dividend||$0 ( N/A )|
|2023-11-07||Shah Pritesh||Sell||382||Ordinary Shares|
|2023-10-31||Puri Michal Nath||Buy||57 604||Stock Option (Right to Buy)|
|2023-10-31||Puri Michal Nath||Buy||37 593||Ordinary Shares|
|2023-10-25||Puri Michal Nath||Buy||0|
|2023-11-02||Cordova Ashley||Buy||175||Ordinary Shares|
|Last 96 transactions|
|Buy: 737 040 | Sell: 116 982|
Novocure Ltd Correlation
|10 Most Positive Correlations|
|10 Most Negative Correlations|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Novocure Ltd Correlation - Currency/Commodity
Novocure Ltd Financials
|Gross Profit:||$422.97M (78.64 %)|
|Gross Profit:||$95.23M (74.79 %)|
|Gross Profit:||$92.03M (73.01 %)|
|Gross Profit:||$92.57M (75.76 %)|
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.